Together, molecular targets distinguishing two distinct pathways of VEGF signaling may provide novel therapies for the treatment of age-related cerebrovascular and neurological diseases and for maintaining lower mortality due to these conditions. This evidence concerns the gene VEGFA and nervous system disorder.